| 000 | 01684 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518040531.0 | ||
| 264 | 0 | _c20190705 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1879-0631 | ||
| 024 | 7 |
_a10.1016/j.lfs.2019.05.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAdhikary, Sulekha | |
| 245 | 0 | 0 |
_aFGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation. _h[electronic resource] |
| 260 |
_bLife sciences _cJul 2019 |
||
| 300 |
_a261-276 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDexamethasone _xtoxicity |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xpharmacology |
| 650 | 0 | 4 |
_aGlucocorticoids _xtoxicity |
| 650 | 0 | 4 |
_aGlycoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aIntercellular Signaling Peptides and Proteins |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aMusculoskeletal Diseases _xchemically induced |
| 650 | 0 | 4 |
_aMyostatin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOsteoblasts _xcytology |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 700 | 1 | _aChoudhary, Dharmendra | |
| 700 | 1 | _aTripathi, Ashish Kumar | |
| 700 | 1 | _aKarvande, Anirudha | |
| 700 | 1 | _aAhmad, Naseer | |
| 700 | 1 | _aKothari, Priyanka | |
| 700 | 1 | _aTrivedi, Ritu | |
| 773 | 0 |
_tLife sciences _gvol. 229 _gp. 261-276 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lfs.2019.05.022 _zAvailable from publisher's website |
| 999 |
_c29684018 _d29684018 |
||